SAEM Clinical Images Series: Tropical Rash

rash

The patient is a 30-year-old female with no past medical history who presents to the Emergency Department with 2 months of non-healing ulcers on multiple parts of her body. She reports getting bitten by flies while traveling in wooded trails from Venezuela through Mexico. She reports the bites started as small scabs that have since enlarged, but they are non-painful or pruritic. She has ulcerative lesions on her left hand, right arm, back, and gluteal areas. She has taken multiple antibiotics from a doctor in Mexico including clindamycin, ceftriaxone, nitrofurantoin, flagyl, and doxycycline. She denies any fevers, chills, nausea, vomiting, weight loss, or night sweats, but given the persistence of the lesions, she comes in for evaluation.

Vitals: BP 143/91 HR 60 R 17 T 98.4 O2sat 100% room air.

General: Well-appearing, breast-feeding her child.

HEENT: Oropharynx is clear, moist mucous membranes, nares clear.
Cardiovascular: Regular rate and rhythm, no murmur.

Skin: There are multiple lesions as shown in the images provided. These
are annular ulcerated pink plaques with erythematous indurated borders
and are located diffusely. The larger lesion shown is on her right arm and
is newer than the other lesions shown on her hand and trunk.

CBC: WBC: 7.6 Hgb 12.2

CRP: 0.3

Hep C/HIV/syphilis/GCCT: negative

This patient has cutaneous leishmaniasis.

Cutaneous leishmaniasis (CL) is caused by the protozoan parasite Leishmania and is transmitted through the bite of an infected female sandfly. CL is commonly diagnosed in travelers and immigrants who are susceptible to exposure. The lesions of CL usually begin as small erythematous papules that increases in size and eventually ulcerate and crust over. Lesions generally have distinct borders that are raised and erythematous. The diagnosis can be made based on travel history, lesion appearance, skin biopsy, and serology. Without treatment, the ulcers heal slowly but can leave disfiguring scars. Treatment modalities include pentamidine, amphotericin B, antimoniate, paromomycin, imiquimod, thermotherapy and cryotherapy. Visceral leishmaniasis (VL) is the most serious form of infection and is almost always fatal if untreated. With VL, the parasites directly infect organs including the spleen, liver, bone marrow, and other viscera. Common signs and symptoms of VL include fever, weight loss, fatigue, weakness, night sweats, hepatosplenomegaly, and pancytopenia.

Take-Home Points

  • Cutaneous Leishmaniasis should be suspected in travelers who have been to endemic areas and present with non-healing skin ulcerations. Visceral Leishmaniasis is the most severe form of disease and carries an extremely high mortality rate if untreated.
  • The vector for this disease is the sandfly; diagnosis is made through skin biopsy and direct microscopy of the parasite.

1. Eiras DP, Kirkman LA, Murray HW. Cutaneous Leishmaniasis: Current Treatment Practices in the USA for Returning Travelers. Curr Treat Options Infect Dis. 2015;7(1):52-62. doi:10.1007/s40506-015-0038-4

2. Chappuis, F., Sundar, S., Hailu, A. et al. Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?. Nat Rev Microbiol 5, 873–882 (2007). https://doi.org/10.1038/nrmicro1748

By |2025-10-27T08:26:58-07:00Oct 3, 2025|Dermatology, SAEM Clinical Images|

SAEM Clinical Images Series: When in Doubt, Swab It Out

eczema

A 26-year-old female with a history of atopic dermatitis presents with one week of rash that began on her lower lip but spread over her face, eyelids, and neck, plus one day of fevers and headache. She was seen at an urgent care and referred to the emergency department for evaluation and management of “impetigo.” On presentation, she endorsed nausea, headache, and mild neck pain.

Vitals: Temp 100.7° F; BP 134/85; HR 121; SpO2: 100%

General: Uncomfortable appearing.

Cardiovascular: Tachycardia

Neurological: AOx3. CN II-XII grossly intact. Moves all extremities equally and spontaneously.

Skin: Upper cutaneous lip – eroded plaque with yellow crust. Bilateral jaw line, cheek, neck, eyelids – eroded papules. Lichenified patches in antecubital fossa bilaterally.

CBC: WBC 10.7; PLT 244

Lactate: 1.31

CSF: Colorless, clear; WBC 1; RBC<1; Protein 23; Glucose 55, Gram Stain Negative

Given the patient’s history of atopic dermatitis and evidence of crusted over papules/pustules on exam, this patient’s presentation was most consistent with diagnosis of eczema herpeticum (EH).

Swabs of the upper lip lesion were positive for HSV1 DNA, which confirmed the diagnosis. Early identification and treatment of EH is critical to preventing dangerous complications including ocular involvement, viremia, meningoencephalitis, hepatitis, or secondary infection with S. aureus resulting in bacteremia. Patients with EH involving the face, periocular areas, or systemic symptoms should be admitted for intravenous antiviral therapy and supportive care.

Take-Home Points

  • The diagnosis of EH is primarily based on history and physical, but the presence of HSV in skin lesions can be confirmed by PCR.
  • Delayed treatment is associated with increased risk of complications and prolonged hospitalization.

1.Wollenberg A, Wetzel S, Burgdorf WH, Haas J. Viral infections in atopic dermatitis: pathogenic aspects and clinical management. J Allergy Clin Immunol. 2003 Oct;112(4):667-74. PMID: 14564342.

2.Aronson PL, Yan AC, Mittal MK, Mohamad Z, Shah SS. Delayed acyclovir and outcomes of children hospitalized with eczema herpeticum. Pediatrics. 2011 Dec;128(6):1161-7. PMID: 22084327.

By |2025-10-27T08:24:25-07:00Sep 29, 2025|Dermatology, SAEM Clinical Images|

ACMT Toxicology Visual Pearl: Danger in the Shallows

In addition to local pain and dermal injury, stings from this marine animal can result in what systemic symptoms?

  1. Acute liver injury
  2. Hypotension, arrhythmia, and cardiac arrest
  3. Nausea, vomiting, and respiratory arrest
  4. Numbness, tingling, and muscle paralysis

[Image courtesy of Guido Gautsch, Wikimedia Commons]

(more…)

The Discharge Severity Index: Early Research on ED Readmission Risk Assessment

discharge severity index DSI

From Triage to Discharge: As an emergency medicine clinician, you’ve likely become comfortable using the Emergency Severity Index (ESI), a critical tool helping triage patients entering the ED. But what happens when these patients leave your care? How can we anticipate who might need extra support to avoid readmission?

Let’s discuss why ED discharge risk stratification matters, the landscape of existing tools, and introduce a new effort called the Discharge Severity Index (DSI), in the context of this evolving conversation.

History of Emergency Severity Index (ESI)

As emergency medicine clinicians, we’ve all become comfortable with using the ESI. It’s simple, intuitive, and has revolutionized triage since its introduction in the late 1990s. ESI stratifies our incoming patients quickly and reliably based on anticipated resource needs and hospitalization risks, making it easy to decide who gets seen first. Over the years, ESI has gone through multiple iterations to better reflect evolving clinical priorities, workflows, and patient populations [1–4]. It became a living tool that is as dynamic and adaptive as emergency care itself.

However, as powerful as ESI is, it addresses only half the equation: what happens when patients arrive. But what about when they leave?

Discharge: More than a Binary Decision

Currently, ED discharge is largely treated as a binary decision—admit or discharge. But think about admissions: we never treat admissions as simple “yes/no” decisions. Patients can go to observation, a floor bed, step-down units, or the ICU. Each has varying resource needs and follow-up intensities. So why don’t we apply this nuanced thinking to discharge?

ED discharges aren’t straightforward. Almost 14% of patients discharged from EDs return within 30 days, often due to issues that could be preventable with better follow-up [5]. Many face barriers like misunderstanding discharge instructions, inadequate social support, and difficulty accessing outpatient care. We have powerful new follow-up tools available (e.g., nursing callback programs, telehealth, remote patient monitoring) but we often lack a clear, systematic way of figuring out which patients truly need them.

Existing Tools and Their Limitations

Multiple scoring systems have attempted to predict post-discharge adverse outcomes. Some prominent examples include:

  • LACE Score:
    • Length of stay
    • Acuity of admission
    • Comorbidities
    • Emergency visits
  • HOSPITAL Score:
    • Hemoglobin level
    • Oncology diagnosis
    • Sodium level
    • Procedure during hospitalization
    • Index admission type
    • Admissions in previous year
    • Length of stay

Yet, many of these tools weren’t specifically designed for the ED population. Our recent scoping review highlighted significant variability, limited ED-specific validation, and complexity that can hinder practical use [6].

Introducing the Discharge Severity Index (DSI): An Early-Stage Tool

Recognizing this gap, our team developed the DSI, an initial attempt at ED-specific discharge risk stratification. The idea behind DSI is to use straightforward, quickly accessible ED data points to identify patients who might benefit from enhanced follow-up.

Our single-center retrospective study analyzed ED visits, dividing the data into the derivation (75%) and validation (25%) cohorts [7]. We attempted to stratify risk based on the DSI score and measuring their 7-day readmission rates.

Our DSI score was calculated using 5 key clinical factors (0=lowest risk, 7=highest risk):

  1. Age > 65 years = 1 point
  2. Heart rate at discharge > 100 bpm = 1 point
  3. Oxygen saturation at discharge < 96% = 1 point
  4. Length of ED stay > 3 hours = 2 points
  5. Active medications > 5 during hospital stay = 2 points

Here’s what we found:

DSI LevelScore7-day Approximate Readmission Risk
1 (highest risk)6-75%
254%
33–43%
41–21%
5 (lowest risk)0<0.5%

A patient scoring a DSI 1 might benefit from immediate follow-up with telehealth, home health visits, and/or increased outpatient support. Conversely, a DSI 4 or 5 patient might safely manage standard outpatient care with minimal risk.

How is DSI Different Existing Scoring Systems?

Unlike the LACE or HOSPITAL scores, the DSI was built specifically for the ED context. It uses data readily available at discharge, allowing rapid identification of patients who may require more intensive post-discharge follow-up. It’s meant for nursing or automated tools to assign this to the patient, without requiring more provider resources.

But, let’s be clear: the DSI is not perfect. We intentionally started simple (similar to how ESI began) to get people thinking about stratifying discharge risks. For instance:

  • Length of Stay (LOS): Right now, LOS includes waiting room times, boarding delays, and other systems-level issues, making it an imperfect measure of medical complexity.
  • Vital Signs at Discharge Only: Using only discharge vitals doesn’t account for patients who had unstable earlier vitals during their ED stay.
  • Missing Comorbidities: The current DSI doesn’t explicitly factor in comorbidities or past medical history, which we know affect patient outcomes.

Why This Matters to You

It’s important to grasp the complexity behind discharge decisions just as clearly as they understand triage. Discharge isn’t simply sending patients home; it’s anticipating what happens next and appropriately preparing patients to succeed.

Implementing structured discharge risk stratification not only supports better clinical outcomes but also helps teach clinicians to think about care beyond the ED walls. With more accurate identification of high-risk patients, residents can be better prepared to integrate innovative follow-up resources into patient care.

Where do we go from here?

The DSI represents an early, evolving concept. We don’t expect it to be adopted widely and imminently. Rather, we hope it sparks a broader conversation similar to the early years of the ESI. ESI began as a simple triage tool and matured through iterative development, field testing, and adaptation across varied ED environments. It became more robust, nuanced, and integrated into daily clinical operations over time. We envision a similar trajectory for the DSI.

Future iterations of the DSI will undoubtedly incorporate additional clinical variables, operational data, and even social determinants of health. But before we get there, the next step is clear: we must operationalize the DSI and test it in multiple real-world settings. Its utility must be validated not just in theory or retrospective data, but in the dynamic, complex ecosystem of actual emergency departments.

We encourage EM educators and residency programs to join us in refining the conversation about ED discharge stratification.

Whether it’s integrating DSI into discharge planning discussions, piloting it during teaching rounds, or evaluating it in post-discharge follow-up workflows, there is now an opportunity to take this idea from concept to practice for the benefit of our patients.

Let’s build upon this first step, creating tools that are practical, teachable, and clinically meaningful. Together, we can ensure that the decision to discharge is just as thoughtful, nuanced, and patient-focused as the decision to admit.

References

  1. Wuerz RC, Milne LW, Eitel DR, Travers D, Gilboy N. Reliability and validity of a new five-level triage instrument. Acad Emerg Med 2000;7(3):236–42.
  2. Wuerz RC, Travers D, Gilboy N, Eitel DR, Rosenau A, Yazhari R. Implementation and refinement of the emergency severity index. Acad Emerg Med 2001;8(2):170–6.
  3. Eitel DR, Travers DA, Rosenau AM, Gilboy N, Wuerz RC. The emergency severity index triage algorithm version 2 is reliable and valid. Acad Emerg Med 2003;10(10):1070–80.
  4. Elshove-Bolk J, Mencl F, van Rijswijck BTF, Simons MP, van Vugt AB. Validation of the Emergency Severity Index (ESI) in self-referred patients in a European emergency department. Emerg Med J 2007;24(3):170–4.
  5. Characteristics of 30-Day All-Cause Hospital Readmissions, 2016-2020 [Internet]. [cited 2025 Jul 7].
  6. Jaffe TA, Wang D, Loveless B, et al. A Scoping Review of Emergency Department Discharge Risk Stratification. West J Emerg Med 2021;22(6):1218–26. PMID 34787544
  7. Kijpaisalratana N, El Ariss AB, Balk A, et al. Development and validation of the discharge severity index for post-emergency department hospital readmissions. Am J Emerg Med. 2025;94:125-132. doi:10.1016/j.ajem.2025.04.045. PMID 40288325
By |2025-08-09T13:19:36-07:00Aug 14, 2025|Administrative, Beyond the Abstract|

ALiEM AIR Series | Vascular Module (2025)

 

Welcome to the AIR Vascular Module! After carefully reviewing all relevant posts in the past 12 months from the top 50 sites of the Digital Impact Factor [1], the ALiEM AIR Team is proud to present the highest quality online content related to related to HEENT emergencies in the Emergency Department. 8 blog posts met our standard of online excellence and were approved for residency training by the AIR Series Board. More specifically, we identified 3 AIR and 5 Honorable Mentions. We recommend programs give 4 hours of III credit for this module.

 

AIR Stamp of Approval and Honorable Mentions

 

In an effort to truly emphasize the highest quality posts, we have 2 subsets of recommended resources. The AIR stamp of approval is awarded only to posts scoring above a strict scoring cut-off of ≥30 points (out of 35 total), based on our scoring instrument. The other subset is for “Honorable Mention” posts. These posts have been flagged by and agreed upon by AIR Board members as worthwhile, accurate, unbiased, and appropriately referenced despite an average score.

 

Take the Vascular Module at ALiEMU

 

Interested in taking the AIR quiz for fun or asynchronous (Individualized Interactive Instruction) credit? Please go to the above link. You will need to create a free, 1-time login account.

 

Highlighted Quality Posts: Vascular 2025

 

SiteArticleAuthorDateLabel
EMCritPulmonary embolism diagnosis and treatment of low-risk PEDr. Josh FarkasMarch 5, 2024

AIR

EMCritAortic dissectionDr. Josh FarkasSeptember 28, 2024AIR
EMDocsAcute chest syndromeDr. Rachel BridwellJune 27, 2024AIR
EMCritApproach to chest painDr. Josh FarkasJanuary 15, 2024HM
Rebel EMDon’t forget the IO in the critically ill patientDr. Kristen WileyApril 29, 2024HM
RCEMlearningCervical artery dissectionDr. Jason LouisJanuary 22, 2024HM
CanadiEMIs IO cannulation an underutilized method of emergency vascular accessDr. Ming LiOctober 15, 2024HM
PedEM MorselsKounis syndromeDr. Christyn MagillMarch 22, 2023HM

 

(AIR = Approved Instructional Resource; HM = Honorable Mention)

 

If you have any questions or comments on the AIR series, or this AIR module, please contact us!

Reference

    1. Lin M, Phipps M, Chan TM, et al. Digital Impact Factor: A Quality Index for Educational Blogs and Podcasts in Emergency Medicine and Critical Care. Ann Emerg Med. 2023;82(1):55-65. doi:10.1016/j.annemergmed.2023.02.011, PMID 36967275

 

 

Go to Top